Literature DB >> 3063483

Heterogeneity of response of peripheral arteries to antihypertensive drugs in essential hypertension. Basic effects and functional consequences.

J Levenson1, A Simon.   

Abstract

The vascular impact of different antihypertensive drugs was assessed in patients with mild to moderate essential hypertension by the use of the forearm circulation as a simple model to characterise the geometrical and distensible properties of the arterial system. The acute and chronic responses of the forearm arteries, expressed in terms of geometry (vasodilatation or vasoconstriction) and distensibility (arterial compliance, pulse-wave velocity), were not solely dependent on blood pressure levels. For similar blood pressure decreases, the dilatation of the forearm resistive vessels was associated either with an increase (calcium antagonists, angiotensin-converting enzyme inhibitors) or with a reduction (hydralazine-like drugs) or with no change (alpha- and beta-blocking drugs) in the calibre of the large forearm vessel. These non-homogeneous geometrical responses to antihypertensive drugs had important haemodynamic effects on the conduit, the buffering and the baroreflex functions of the arterial tree.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063483     DOI: 10.2165/00003495-198800355-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  25 in total

Review 1.  Vasodilatation of small and large arteries in hypertension.

Authors:  J A Levenson; A C Simon; M E Safar
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

2.  Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans.

Authors:  H Ibsen; B Egan; K Osterziel; A Vander; S Julius
Journal:  Hypertension       Date:  1983 Mar-Apr       Impact factor: 10.190

3.  Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress.

Authors:  D N Ku; D P Giddens; C K Zarins; S Glagov
Journal:  Arteriosclerosis       Date:  1985 May-Jun

4.  Effects of acute and chronic angiotensin-converting enzyme inhibition on large arteries in human hypertension.

Authors:  A C Simon; J A Levenson; J Bouthier; B Maarek; M E Safar
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

5.  Captopril-induced changes in large arteries in essential hypertension.

Authors:  A C Simon; J A Levenson; J L Bouthier; M E Safar
Journal:  Am J Med       Date:  1984-05-31       Impact factor: 4.965

6.  Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.

Authors:  J Levenson; A C Simon; M E Safar; J Bouthier; B C Maarek
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

Review 7.  Overview on atherosclerotic systolic hypertension.

Authors:  A Simon; J Levenson
Journal:  Int J Cardiol       Date:  1987-07       Impact factor: 4.164

8.  Effects of chronic administration of enalapril and propranolol on the large arteries in essential hypertension.

Authors:  A C Simon; J Levenson; J D Bouthier; M E Safar
Journal:  J Cardiovasc Pharmacol       Date:  1985 Sep-Oct       Impact factor: 3.105

9.  The role of antihypertensive drugs in counteracting adverse influence on large arteries.

Authors:  J Levenson; K H Le Quan Sang; M A Devynck; R Gitel; A Simon
Journal:  Am Heart J       Date:  1987-10       Impact factor: 4.749

10.  Evidence of early degenerative changes in large arteries in human essential hypertension.

Authors:  A C Simon; J Levenson; J Bouthier; M E Safar; A P Avolio
Journal:  Hypertension       Date:  1985 Sep-Oct       Impact factor: 10.190

View more
  3 in total

Review 1.  Impact of calcium antagonists on the cardiovascular system: experience with lacidipine.

Authors:  E Kuschnir
Journal:  Drugs       Date:  1999       Impact factor: 9.546

2.  Amlodipine induces a flow and pressure-independent vasoactive effect on the brachial artery in hypertension.

Authors:  J L Megnien; J Levenson; M Del-Pino; A Simon
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

Review 3.  Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.

Authors:  B Dahlöf
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.